Shiva Shankaran Chettiar

Shiva Shankaran Chettiar

Active Director Director DIN 07917469
DIN 07917469 First appointment Aug 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 11 active board seats
Total affiliations 11 Since Aug 2017
Shareholding value •••• Premium profile

About Shiva Shankaran Chettiar

Data last updated:

Shiva Shankaran Chettiar is a Director at Genexplore Diagnostics And Research Center Private Limited (since 2017), Director at Anagram Atgc Private Limited (since 2022) and Designated Partner at Genexplore Medisquare Diagnostics Center Llp (since 2021), and holds 8 more current directorships. The companies operate in Healthcare, Research & Development and Professional Services. The 4 current companies with reported revenue have a combined latest revenue of ₹9.75 Cr; the largest is Genexplore Diagnostics And Research Center Private Limited at ₹6.21 Cr (FY 2023).

DIN 07917469
Primary Designation Director
Industry Healthcare
First Appointment 24 Aug 2017
Oldest Company Age 12 yrs
Largest company Genexplore Diagnostics And Research Center Private Limited · ₹6.21 Cr (FY 2023)
Combined revenue ₹9.75 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Aug 20172013₹6.21 Cr (FY 2023)Active
Anagram Atgc Private Limited U73100GJ2022PTC129815
Director03 Mar 20222022₹2.87 Cr (FY 2024)Active
Designated Partner12 Jul 20212021₹47.9 Lakh (FY 2023)Active
Designated Partner09 Jul 20212021₹19.2 Lakh (FY 2023)Active
Swatha Healthcare Private Limited U86909GJ2025PTC165403
Director23 Jul 20252025Active
Designated Partner07 Jun 20242024Active
Designated Partner19 Dec 20232023Active
Designated Partner28 Jul 20232023Active

Board colleagues of Shiva Shankaran Chettiar

NameDINCompanyDesignation
Alpesh Ramanlal Patel06675599Genexplore Diagnostics And Research Center Private Limited , Anagram Research Solutions Llp and 1 moreDirector
Ashokbhai Patel Ramanlal07917505Genexplore Diagnostics And Research Center Private LimitedDirector
Pareshkumar Kanubhai Patel07917530Genexplore Diagnostics And Research Center Private Limited , Anagram Research Solutions LlpDirector
Payal Devendrasinh Jhala07917525Genexplore Diagnostics And Research Center Private Limited , Anagram Atgc Private LimitedDirector
Hina Patel09525680Anagram Atgc Private LimitedDirector
Pushpaben Pareshkumar Patel09525681Anagram Atgc Private LimitedDirector
Reeta Ashokbhai Patel09525682Anagram Atgc Private LimitedDirector
Nirmal Bhasin09217903Genexplore Medisquare Diagnostics Center LlpDesignated Partner
Vipul Kalyanji Chhatbar00303376Genexplore Medisquare Diagnostics Center Llp , Medispec Genexplore Diagnostics Center LlpDesignated Partner
Vidhi Rathi09234365Genexplore Shivani Diagnostics And Research Center LlpDesignated Partner
Supriya Anand08523620Swatha Healthcare Private LimitedDirector
Anjanaben Dhirajlal Ghelani10661345Floragen Biologicals LlpDesignated Partner
Jayeshkumar Rameshlal Prajapati10431663Anagram Research Solutions LlpDesignated Partner
Vinod Brijnandan Baghel10259522Svaja Medilaw Services India LlpDesignated Partner
Nikita Vipul Chhatbar00303497Medispec Genexplore Diagnostics Center LlpDesignated Partner
Sarfaraz Hussain Farooqui09189395Genexplore Crisptales Diagnostics And Research Centre LlpDesignated Partner
Twinkle Jitendrakumar Dhamecha08701118Wepath Genexplore Laboratory LlpDesignated Partner
Varun Jagdish Gohil09199739Wepath Genexplore Laboratory LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Wepath Genexplore Laboratory Llp
Anagram Atgc Private Limited
Genexplore Diagnostics And Research Center Private Limited
Medispec Genexplore Diagnostics Center Llp
Premium access

Shareholding and investment profile for Shiva Shankaran Chettiar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shiva Shankaran Chettiar

Shiva Shankaran Chettiar currently holds 11 directorships: Genexplore Diagnostics And Research Center Private Limited (Director, since 24 Aug 2017, revenue ₹6.21 Cr (FY 2023)); Anagram Atgc Private Limited (Director, since 03 Mar 2022, revenue ₹2.87 Cr (FY 2024)); Genexplore Medisquare Diagnostics Center Llp (Designated Partner, since 12 Jul 2021, revenue ₹47.9 Lakh (FY 2023)); Genexplore Shivani Diagnostics And Research Center Llp (Designated Partner, since 09 Jul 2021, revenue ₹19.2 Lakh (FY 2023)); Swatha Healthcare Private Limited (Director, since 23 Jul 2025); and 6 more.

Shiva Shankaran Chettiar was first appointed on 24 Aug 2017 as Director at Genexplore Diagnostics And Research Center Private Limited. The most recent appointment on record is 23 Jul 2025 at Swatha Healthcare Private Limited.

The 4 current companies of Shiva Shankaran Chettiar that report revenue have a combined latest revenue of ₹9.75 Cr: Genexplore Diagnostics And Research Center Private Limited ₹6.21 Cr (FY 2023); Anagram Atgc Private Limited ₹2.87 Cr (FY 2024); Genexplore Medisquare Diagnostics Center Llp ₹47.9 Lakh (FY 2023); Genexplore Shivani Diagnostics And Research Center Llp ₹19.2 Lakh (FY 2023).

The current boards of Shiva Shankaran Chettiar's companies include Alpesh Ramanlal Patel (Genexplore Diagnostics And Research Center Private Limited), Ashokbhai Patel Ramanlal (Genexplore Diagnostics And Research Center Private Limited), Pareshkumar Kanubhai Patel (Genexplore Diagnostics And Research Center Private Limited), Payal Devendrasinh Jhala (Genexplore Diagnostics And Research Center Private Limited), Hina Patel (Anagram Atgc Private Limited), Pushpaben Pareshkumar Patel (Anagram Atgc Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available